FitzPatrick Margaret M
Insider trades filed on SEC Form 4, newest first. SEC CIK 0001873879.
- 12
- Form 4 lines on record
- 2
- Purchases (code P)
- 0
- Sales (code S)
- Sep 2, 2026, 8:43 PM ET
- Latest filing
Companies FitzPatrick Margaret M reports for
- AN2 Therapeutics, Inc. ANTX, DirectorLast filed Sep 2, 2026, 6:43 PM ET
- Vistagen Therapeutics, Inc. VTGN, DirectorLast filed Sep 11, 2025, 6:15 PM ET
Holdings
LockedShares owned after each company's most recent Form 4, valued at the current price. Part of InsiderScanner.
- Filed Sep 2, 2026, 6:43 PM ET (open the Form 4 on EDGAR)Purchase (code P)Buy
ANTXAN2 Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Mar 23, 2026, 7:09 PM ET (open the Form 4 on EDGAR)Award/GrantOther
ANTXAN2 Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Mar 23, 2026, 7:09 PM ET (open the Form 4 on EDGAR)Award/GrantOther
ANTXAN2 Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
ANTXAN2 Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
ANTXAN2 Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Mar 23, 2026, 7:09 PM ET (open the Form 4 on EDGAR)Award/GrantOther
ANTXAN2 Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
ANTXAN2 Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Feb 23, 2026, 4:17 PM ET (open the Form 4 on EDGAR)Award/GrantOther
ANTXAN2 Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Sep 11, 2025, 6:15 PM ET (open the Form 4 on EDGAR)Award/GrantOther
VTGNVistagen Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed May 29, 2025, 4:17 PM ET (open the Form 4 on EDGAR)Purchase (code P)Buy
ANTXAN2 Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed May 23, 2025, 4:59 PM ET (open the Form 4 on EDGAR)Award/GrantOther
ANTXAN2 Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Sep 10, 2024, 5:00 PM ET (open the Form 4 on EDGAR)Award/GrantOther
VTGNVistagen Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
Shares, price, value, trade date and holdings after the trade are locked on 12 rows here. Included with InsiderScanner ($9.99 a month) and Signal8 Pro.
Unlock with InsiderScanner